R2032898 |
AS1842856 |
AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophag
|
R2032899 |
BIBS39 |
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.Target: Ang
|
R2032900 |
CCT245737 |
CCT245737 is an orally active and seletive Chk1 inhibitor, with an IC50 of 1.3 n
|
R2032901 |
Grapiprant |
Grapiprant (CJ-023423) is a selective EP4 receptor antagonist whose physiologica
|
R2032902 |
HG-14-10-04 |
HG-14-10-04 is a potent and specific ALK inhibitor with IC50 of 20 nM.IC50 value
|
R2032903 |
WNK463 |
WNK463 is an orally bioavailable pan-With-No-Lysine (K) (WNK)-kinase inhibitor w
|
R2032904 |
AZD5153 |
AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153.
|
R2032905 |
GGTI298 Trifluoroacetate |
GGTI298 Trifluoroacetate is a CAAZ peptidomimetic geranylgeranyltransferase I (G
|
R2032906 |
INF39 |
INF39 is an irreversible and noncytotoxic NLRP3 inhibitor.
|
R2032907 |
ML213 |
ML213 is a selective activator of Kv7.2 and Kv7.4 channels, enhances Kv7.2 and K
|
R2032908 |
NCB-0846 |
NCB-0846 is an orally available TNIK inhibitor with an IC50 of 21 nM.
|
R2032909 |
Sapacitabine |
Sapacitabine is an orally available nucleoside analog prodrug that is structural
|
R2032910 |
STAT5 |
STAT5-IN-1 is a STAT5 inhibitor with an IC50 of 47 μM for STAT5β isoform.
|
R2032911 |
TM5441 |
TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1
|
R2032912 |
A-1331852 |
A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less th
|
R2032913 |
AMG-3969 |
AMG-3969 is a potent glucokinase-glucokinase regulatory protein interaction (GK-
|
R2032914 |
Belizatinib(TSR011) |
Belizatinib is an oral, dual, potent inhibitor of ALK and TRKA, TRKB, and TRKC,
|
R2032915 |
BI605906 |
BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at
|
R2032916 |
BMS378806 |
BMS-378806 is a potent HIV-1 attachment inhibitor that interferes with CD4-gp120
|
R2032917 |
BMS-986020 |
BMS-986020 is a high-affinity and selective lysophosphatidic acid receptor 1 (LP
|
R2032918 |
Cenerimod(ACT-334441) |
Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate
|
R2032919 |
CZC25146 |
CZC-25146 is a potent, selective and metabolically stable LRRK2 inhibitor with I
|
R2032920 |
ETP-46321 |
ETP-46321 is a potent and orally bioavailable PI3Kα and PI3Kδ inhibitor with Kia
|
R2032921 |
JPH203 |
JPH203 is a potent and selective L-type amino acid transporter 1 (LAT-1) inhibit
|
R2032922 |
Q203 |
Q203 (IAP6) is a midazopyridine amide compound.Q203 is active against Mycobacter
|